Gotham founds cancer research prize

Two hedge fund managers have joined forces with scientists to launch a $1 million prize for cancer research.
MAY 23, 2007
Two hedge fund managers have joined forces with scientists to launch a $1 million prize for cancer research. Joel Greenblatt and Robert Goldstein of Gotham Capital in New York have teamed up with Dr. Gary Curhan of Harvard Medical School to create the Gotham Prize for Cancer Research. The award, to be given annually, will go to researchers with groundbreaking ideas in the prevention, etiology, diagnosis and treatment of cancer. Additional support came from Ephi Gildor of Axiom Investment Advisors and the Ira Sohn Conference Foundation, which was named after a Wall Street trader who died of cancer. The foundation also awards an annual $250,000 prize in pediatric oncology. Mr. Goldstein was inspired to create the Gotham Prize after his mother, Hope Goldstein, died from ovarian cancer. This year’s Gotham Prize winners will be announced in February 2008.

Latest News

Stratos Wealth Holdings closes 11 acquisitions in push for advisory scale
Stratos Wealth Holdings closes 11 acquisitions in push for advisory scale

RIA aggregator adds $4.8 billion in client assets across seven states as demand grows for alternatives to traditional succession models.

Beyond wealth management: Why the future of advice is becoming more human
Beyond wealth management: Why the future of advice is becoming more human

As technical expertise becomes increasingly commoditized, advisors who can integrate strategy, relationships, and specialized expertise into a cohesive client experience will define the next era of wealth management

Shareholder sues FS KKR Capital board, alleges NAV and dividend cover-up
Shareholder sues FS KKR Capital board, alleges NAV and dividend cover-up

Shareholder targets FS KKR Capital's directors over alleged portfolio valuation and dividend missteps.

UBS loses $1.2 million arbitration claim linked to variable annuities and margin
UBS loses $1.2 million arbitration claim linked to variable annuities and margin

UBS has a history of costly litigation stemming from the sale of volatile investment products.

'We are monitoring the situation,' SEC says of private funds
'We are monitoring the situation,' SEC says of private funds

New director David Woodcock puts firms on notice over fees, conflicts, and liquidity risk as private credit shows signs of stress.

SPONSORED Beyond wealth management: Why the future of advice is becoming more human

As technical expertise becomes increasingly commoditized, advisors who can integrate strategy, relationships, and specialized expertise into a cohesive client experience will define the next era of wealth management

SPONSORED Durability over scale: What actually defines a great advisory firm

Growth may get the headlines, but in my experience, longevity is earned through structure, culture, and discipline